Tag: biotechnology
-
Biotech Company Consolidates, Cuts Workforce 13%
Biogen Idec, a biotechnology company in Weston, Massachusetts, says it will focus its R&D and manufacturing efforts in the field of neurology, cutting its expenses and workforce in the process. The restructuring announced today (3 November) will mean closing its San Diego, California site, and consolidating its Massachusetts operations. The company says it will concentrate…
-
Four Biotechs Land Affordable Care Act Grants
Four biotechnology companies reported the awarding of grants under a provision in the Patient Protection and Affordable Care Act of 2010, known popularly as the Affordable Care Act. The Act adds to Section 48D of the Internal Revenue Code a provision called the Qualifying Therapeutic Discovery Project Credit. This credit funds projects that show potential…
-
Biotech Company Gets Affordable Care Act Grant
Cancer diagnostics company Biomoda Inc. in Albuquerque, New Mexico says it received a grant of more than $244,000 under a provision in Patient Protection and Affordable Care Act of 2010, known popularly as the Affordable Care Act. The grant will fund pilot and later-stage clinical trials of the company’s CyPath diagnostic assay for the detection…
-
Macular Degeneration Test Company Gets Investment
The Ontario Genomics Institute (OGI) in Toronto said today it has made an investment in molecular diagnostics company, ArcticDx Inc., also in Toronto. ArcticDx has developed Macula Risk, a test designed to determine one’s inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10%…
-
Clinical Sample Biobank Slated for Qatar
A collection of samples and clinical measurements from tens of thousands of people is to be opened in Qatar, an Arab Gulf country, to help scientists understand the causes of major diseases and develop new treatments. The project was announced today at the Royal Society in London during a visit from Her Highness Sheikha Mozah…
-
Start Up Licenses Nuclear Imaging Drug Compounds
Clarity Pharmaceuticals Pty Ltd, a new company in Australia, has licensed technology developed by the University of Melbourne and the Australian Nuclear Science and Technology Organisation (ANSTO). The technology involves compounds developed by scientists from ANSTO and the University of Melbourne for use in positron emission tomography. Positron emission tomography (PET) is a test that…
-
Drug Discovery Company Lands $25M in Private, State Funding
Omeros Corporation, a Seattle, Washington biopharmaceutical company focused on inflammation and disorders of the central nervous system, says it has received $20 million from Vulcan Capital and a grant award for $5 million from Washington State’s Life Sciences Discovery Fund (LSDF) to finance the company’s G protein-coupled receptor program. G-protein-coupled receptors (GPCRs) are a large…
-
Plant Stem Cells Point to Cheaper Cancer Drug
A research team from University of Edinburgh in Scotland and Unwha Biotech, a company in Jeonju Si, Korea, has found a way of using stem cells from tree bark that could lead to a simpler and lower-cost process for making the cancer drug paclitaxel. The drug is used to treat lung, ovarian, breast, head, and…
-
Analytical Service Partners with Cancer Drug Makers
Predictive Biomarker Sciences (PBS-Bio) in Mesa, Arizona said today that it signed new contracts with three companies developing therapies against a variety of cancers. PBS-Bio’s analysis helps pharmaceutical companies better understand how their drugs work, and identifies biomarkers that can help predict which patients will respond to treatment. The company’s three new pharmaceutical partners include:…
-
Indian Biotech Develops Cell-Culture H1N1 Vaccine
Bharat Biotech in Hyderabad, India said today it developed India’s first cell-culture H1N1 swine flu vaccine. The company believes it is the only developing world flu vaccine to be manufactured in cell culture, a faster and more advanced manufacturing process, instead of eggs. Traditional egg-based flu vaccine production requires long lead times — four to…